# Minerals Technologies Inc: overview

MTX · NYSE · CIK 891014 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtx.md) · [Financials](/companies/mtx/financials.md) · [Filings](/companies/mtx/filings.md) · [Insiders](/companies/mtx/insiders.md)

Latest reported revenue: [$548.4m](/filings/0000891014-26-000167.md) for Q2 FY2026, three months to 2026-07-05, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000891014-26-000167).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-05) | Q2 FY2026 (2026-07-05) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [525](/filings/0000891014-25-000162.md) | [518 d](/filings/0000891014-26-000067.md) | [492](/filings/0000891014-26-000108.md) | [529](/filings/0000891014-26-000167.md) | [532](/filings/0000891014-25-000162.md) | [520 d](/filings/0000891014-26-000067.md) | [547](/filings/0000891014-26-000108.md) | [548](/filings/0000891014-26-000167.md) |
| Gross margin | % | [25.8%](/filings/0000891014-25-000162.md) | [25.6% d](/filings/0000891014-26-000067.md) | [24.3%](/filings/0000891014-26-000108.md) | [25.9%](/filings/0000891014-26-000167.md) | [25.7%](/filings/0000891014-25-000162.md) | [24.0% d](/filings/0000891014-26-000067.md) | [24.0%](/filings/0000891014-26-000108.md) | [24.4%](/filings/0000891014-26-000167.md) |
| Operating margin | % | [14.6%](/filings/0000891014-25-000162.md) | [16.2% d](/filings/0000891014-26-000067.md) | [(32.6%)](/filings/0000891014-26-000108.md) | [14.1%](/filings/0000891014-26-000167.md) | [13.3%](/filings/0000891014-25-000162.md) | [11.9% d](/filings/0000891014-26-000067.md) | [10.7%](/filings/0000891014-26-000108.md) | [(40.2%)](/filings/0000891014-26-000167.md) |
| Net margin | % | [8.9%](/filings/0000891014-25-000162.md) | [10.4% d](/filings/0000891014-26-000067.md) | [(29.3%)](/filings/0000891014-26-000108.md) | [8.6%](/filings/0000891014-26-000167.md) | [8.1%](/filings/0000891014-25-000162.md) | [7.2% d](/filings/0000891014-26-000067.md) | [6.6%](/filings/0000891014-26-000108.md) | [(33.5%)](/filings/0000891014-26-000167.md) |
| Diluted EPS | $ per share | [1.45](/filings/0000891014-25-000162.md) | not reported | [(4.51)](/filings/0000891014-26-000108.md) | [1.44](/filings/0000891014-26-000167.md) | [1.37](/filings/0000891014-25-000162.md) | not reported | [1.17](/filings/0000891014-26-000108.md) | [(5.90)](/filings/0000891014-26-000167.md) |
| Free cash flow | $m | [35.3 d](/filings/0000891014-25-000162.md) | [42.3 d](/filings/0000891014-26-000067.md) | [(22.7)](/filings/0000891014-26-000108.md) | [33.8 d](/filings/0000891014-26-000167.md) | [43.6 d](/filings/0000891014-25-000162.md) | [31.9 d](/filings/0000891014-26-000067.md) | [9.0](/filings/0000891014-26-000108.md) | [35.8 d](/filings/0000891014-26-000167.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,858](/filings/0000891014-24-000014.md) | [2,126](/filings/0000891014-25-000018.md) | [2,170](/filings/0000891014-26-000067.md) | [2,119](/filings/0000891014-26-000067.md) | [2,073](/filings/0000891014-26-000067.md) |
| Gross margin | % | [24.0%](/filings/0000891014-24-000014.md) | [21.9%](/filings/0000891014-25-000018.md) | [23.4%](/filings/0000891014-26-000067.md) | [25.9%](/filings/0000891014-26-000067.md) | [25.0%](/filings/0000891014-26-000067.md) |
| Operating margin | % | [12.7%](/filings/0000891014-24-000014.md) | [10.1%](/filings/0000891014-25-000018.md) | [7.9%](/filings/0000891014-26-000067.md) | [13.5%](/filings/0000891014-26-000067.md) | [2.3%](/filings/0000891014-26-000067.md) |
| Net margin | % | [8.8%](/filings/0000891014-24-000014.md) | [5.7%](/filings/0000891014-25-000018.md) | [3.9%](/filings/0000891014-26-000067.md) | [7.9%](/filings/0000891014-26-000067.md) | [(0.9%)](/filings/0000891014-26-000067.md) |
| Diluted EPS | $ per share | [4.86](/filings/0000891014-24-000014.md) | [3.73](/filings/0000891014-25-000018.md) | [2.58](/filings/0000891014-26-000067.md) | [5.17](/filings/0000891014-26-000067.md) | [(0.59)](/filings/0000891014-26-000067.md) |
| Free cash flow | $m | [146](/filings/0000891014-24-000014.md) | [23.4](/filings/0000891014-25-000018.md) | [140](/filings/0000891014-26-000067.md) | [147](/filings/0000891014-26-000067.md) | [86.6](/filings/0000891014-26-000067.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mtx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $361.7m | 4,890,106 |  | Added +79,363 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $343.0m | 4,637,632 |  | Added +373,174 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $147.1m | 1,989,019 |  | Added +14,285 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $142.8m | 1,930,086 |  | Added +28,728 |
| [NOMURA ASSET MANAGEMENT INTERNATIONAL INC.](/funds/921739.md) | 2026-06-30 | $126.0m | 1,704,059 |  | Added +249,154 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $103.1m | 1,394,141 |  | Added +26,591 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $93.6m | 1,265,488 |  | Added +56,218 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $76.1m | 1,028,272 |  | Added +70,791 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $48.3m | 652,901 |  | Added +183,429 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $45.0m | 607,837 |  | Added +46,932 |

## Recent filings

[All 2,304 filings](/companies/mtx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:04 ET | [8-K](/filings/0000891014-26-000201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000891014-26-000201 |
| 2026-10-21 | 16:33 ET | [8-K](/filings/0000891014-26-000197.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000891014-26-000197 |
| 2026-10-13 | 16:58 ET | [8-K](/filings/0000950157-26-001098.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950157-26-001098 |
| 2026-10-02 | 16:23 ET | [8-K](/filings/0000950157-26-001063.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950157-26-001063 |
| 2026-10-01 | 08:22 ET | [8-K](/filings/0000950157-26-001054.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950157-26-001054 |
| 2026-07-31 | 15:01 ET | [10-Q](/filings/0000891014-26-000167.md) | Quarterly report, period 2026-07-05 | 0000891014-26-000167 |
| 2026-07-30 | 17:02 ET | [8-K](/filings/0000891014-26-000164.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000891014-26-000164 |
| 2026-07-22 | 16:29 ET | [8-K](/filings/0000891014-26-000160.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000891014-26-000160 |
| 2026-06-29 | 17:02 ET | [8-K](/filings/0000891014-26-000155.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000891014-26-000155 |
| 2026-05-20 | 15:00 ET | [8-K](/filings/0000891014-26-000117.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000891014-26-000117 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000891014-26-000067.md), filed Feb 20, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 891014
- Tickers: MTX
- Exchange: NYSE
- SIC code: 2810 Industrial Inorganic Chemicals
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 15:40 ET. No prices; not investment advice.